Statistics
Total Visits
Views | |
---|---|
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: A hellenic cooperative oncology group study | 185 |
Total Visits Per Month
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: A hellenic cooperative oncology group study | 25 | 0 | 8 | 4 | 4 | 5 | 6 |
Top country views
Views | |
---|---|
United States | 90 |
Poland | 54 |
China | 8 |
Sweden | 6 |
Ireland | 4 |
France | 3 |
Brazil | 2 |
India | 2 |
Mongolia | 2 |
Ukraine | 2 |
Top cities views
Views | |
---|---|
Warsaw | 54 |
San Mateo | 25 |
Louisville | 16 |
Boardman | 7 |
San Ramon | 7 |
Ann Arbor | 6 |
Menlo Park | 5 |
Ashburn | 4 |
Beijing | 4 |
Des Moines | 4 |